PT  - JOURNAL ARTICLE
AU  - Wolfgang Geidl
AU  - Sabrina Schlesinger
AU  - Eriselda Mino
AU  - Lorena Miranda
AU  - Klaus Pfeifer
TI  - Dose–response relationship between physical activity and mortality in adults with noncommunicable diseases: A systematic review and meta-analysis of cohort studies
AID  - 10.1101/2019.12.18.19014340
DP  - 2019 Jan 01
TA  - medRxiv
PG  - 2019.12.18.19014340
4099  - http://medrxiv.org/content/early/2019/12/18/2019.12.18.19014340.short
4100  - http://medrxiv.org/content/early/2019/12/18/2019.12.18.19014340.full
AB  - Objective To investigate the relationship between post-diagnosis physical activity and mortality in patients with selected noncommunicable diseases, including breast cancer, lung cancer, type 2 diabetes (T2D), ischemic heart disease (IHD), chronic obstructive pulmonary disease (COPD), stroke, osteoarthritis, low back pain and major depressive disorders.Design Systematic review and dose–response meta-analysis.Data sources PubMed, Scopus and the Web of Science were searched systematically for English publications from the inception of the platforms until August 2018. Additionally, the search was updated in August 2019.Eligibility criteria Prospective observational studies examining the relationship between at least three physical activity categories and all-cause mortality or disease-specific mortality as the primary outcome.Results In total, 28 studies were included: 12 for breast cancer, 6 for T2D, 8 for IHD and 2 for COPD. The linear meta-analysis revealed that each 10 metabolic equivalent tasks (MET) h increase of physical activity per week was associated with a 22% lower mortality rate in breast cancer patients (Hazard Ratio [HR], 0.78; 95% CI: 0.71, 0.86), 12% in IHD patients (HR, 0.88; 95% CI: 0.83, 0.93), 30% in COPD patients (HR, 0.70; 95% CI: 0.45, 1.09) and 4% in T2D patients (HR, 0.96; 95% CI: 0.93, 0.99). The non-linear meta-analysis showed a regressive association with no threshold for the beneficial effect of physical activity on mortality.Conclusion Higher levels of post-diagnosis physical activity are associated with lower mortality rates in breast cancer, T2D, IHD and COPD patients, with evidence of a no-threshold and non-linear dose–response pattern.Existing findings- Higher levels of physical activity are associated with a clear reduction in all-cause mortality in the general population.- In the general population, the shape of the dose–response curve between levels of physical activity and reduced mortality rates is characterized by a regressive, non-linear effect.New findings- Higher levels of post-diagnosis physical activity are associated with a clear reduction in all-cause mortality in adults with breast cancer, T2D, IHD and COPD.- The shape of the indication-specific dose–response curves between post-diagnosis physical activity and mortality are characterized by a regressive, non-linear association with (1) no threshold for the beneficial effect, (2) pronounced reductions of mortality for lower levels of physical activity compared to those who are physically inactive and (3) no harmful effects at higher levels of physical activity.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialPROSPERO (the International Prospective Register of Systematic Reviews) registration number: CRD42018103357Funding StatementThis research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData (including the extracted contents from the searched articles) are available upon reasonable request from Dr. Wolfgang Geidl; mail: wolfgang.geidl{at}fau.de